Delivery Order SPE2DB22D3010-SPE2DB25FP0TY

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.80 firm fixed-price delivery order covers the procurement of 4,567,343,614 units of Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,259.88 firm fixed-price delivery order is for the supply of Mesalamine DR 400 mg capsules, and has an ultimate completion date of May 4, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mesalamine DR 400 mg capsules, valued at $10,053.40, with a completion date of November 29, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,718.71 firm fixed price delivery order is for the supply of 180 capsules of the prescription drug Mesalamine DR 400 mg. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 with a performance...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,264.50 firm fixed-price delivery order is for the supply of 120 capsules of Mesalamine ER 0.375 gram, a medication used to treat certain gastrointestinal conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,554.27 firm fixed-price delivery order is for the supply of 180 units of the medication Mesalamine DR 400 mg capsules. The award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of 4,566,640,760 units of the pharmaceutical product Mesalamine DR 400 mg capsules in bottles of 180 units. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $1,130.13 and is a firm fixed-price delivery order contract with a completion date of December 9, 2024. This contract is...
This federal contract award is for the delivery of 120 capsules of Mesalamine ER 0.375 gram to the Defense Logistics Agency (DLA). The $1,261.36 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract has a period of performance through November 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of 180 capsules of Mesalamine DR 400 mg, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $4,386.03 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,059.26 firm fixed-price delivery order is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a medication used to treat certain gastrointestinal conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP0TY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,611.57 Firm Fixed Price Delivery Order is for the supply of 4566188528 Mesalamine DR 400 mg capsules, with a completion date of October 24, 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award was not designated with any set-aside requirements, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 1/22/25, 9:12 AM